Crescent Biopharma (CBIO) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.53% |
| Dec 31, 2025 | -21.68% |
| Sep 30, 2025 | -9.47% |
| Jun 30, 2025 | -2.65% |
| Mar 31, 2025 | -25.34% |
| Dec 31, 2024 | 13.31% |
| Jun 30, 2024 | 4.96% |
| Mar 31, 2024 | 6.08% |
| Dec 31, 2023 | 5.37% |
| Sep 30, 2023 | 2.98% |
| Jun 30, 2023 | 11.79% |
| Mar 31, 2023 | -2.57% |
| Dec 31, 2022 | 1.20% |
| Sep 30, 2022 | -6.60% |
| Jun 30, 2022 | -21.01% |
| Mar 31, 2022 | -8.53% |
| Dec 31, 2021 | -14.08% |
| Sep 30, 2021 | -17.84% |
| Jun 30, 2021 | -13.92% |
| Mar 31, 2021 | -8.85% |
| Dec 31, 2020 | -6.96% |
| Sep 30, 2020 | -23.31% |
| Jun 30, 2020 | -18.06% |
| Mar 31, 2020 | 16.62% |
| Dec 31, 2019 | -15.73% |
| Sep 30, 2019 | -22.63% |
| Jun 30, 2019 | -26.63% |
| Mar 31, 2019 | -40.79% |
| Dec 31, 2018 | -12.47% |
| Sep 30, 2018 | -24.15% |
| Jun 30, 2018 | -36.80% |
| Mar 31, 2018 | -21.37% |